Vanguard Capital Management’s Instil Bio TIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.19M Hold
163,738
– – ﹤0.01% 3516
2026
Q2
$1.26M Sell
163,738
-10,845
-6% -$87.5K ﹤0.01% 3547
2026
Q1
$1.44M Buy
+174,583
New +$1.42M ﹤0.01% 3470

Other funds holding TIL

Vanguard Capital Management's TIL Position: Q3 2026 in Review

Vanguard Capital Management held its Instil Bio (TIL) position steady in Q3 2026 at 163,738 shares worth $1.19M. The position accounts for ﹤0.01% of the portfolio, ranked #3516.

Vanguard Capital Management first reported a position in TIL in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.44M in Q1 2026. 25 funds tracked by Wall St. Rank hold TIL as of Q3 2026.

  • Vanguard Capital Management held 163,738 shares of Instil Bio worth $1.19M as of Q3 2026.
  • Vanguard Capital Management left its Instil Bio share count unchanged in Q3 2026.
  • Instil Bio made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3516 holding.
  • Vanguard Capital Management first reported a position in Instil Bio in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Instil Bio position peaked at $1.44M in Q1 2026.
  • 25 funds tracked by Wall St. Rank held Instil Bio as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.